Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5.

Autor: Bobba, Kondapa Naidu, Bidkar, Anil P., Wadhwa, Anju, Meher, Niranjan, Drona, Suchi, Sorlin, Alexandre M., Bidlingmaier, Scott, Li Zhang, Wilson, David M., Emily Chan, Greenland, Nancy Y., Aggarwal, Rahul, VanBrocklin, Henry F., Jiang He, Jonathan Chou, Youngho Seo, Bin Liu, Flavell, Robert R.
Zdroj: Theranostics; 2024, Vol. 14 Issue 4, p1344-1360, 17p
Databáze: Complementary Index